Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Discover Device Therapies for Heart Failure on Webcast

OSUWexnerbloglogo2014 Discover Device Therapies for Heart Failure on Webcast. In the past, we could prescribe medications or do a heart transplant, but that was about it. Now we have new devices that can help our patients with heart failure. On this CME webcast, we’re going to hear about these new devices to show you how these treatments can help them live longer and better lives. Joining our moderator in the studio are cardiologists and heart failure experts from the Ohio State University. Dr. Rami Kahwash is an Associate Professor of Internal Medicine and he is the Director of the Cardiovascular Research Organization at OSU. And Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the primary prevention strategies of the prevention of sudden cardiac death in chronic systolic heart failure and the role of Cardiac Resynchronization therapy (CRT); and UNDERSTAND indications of the new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • Medications versus implantable cardiac defibrillators
  • Implantable cardiac monitoring devices
  • Precautions when caring for patients with a ventricular assist device
  • Complications of ventricular assist devices
  • Investigational devices
  • Current role of the intra-aortic balloon pump

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches on Anticoagulation and New Anticoagulants

OSUWexnerbloglogo2014 Webcast Teaches on Anticoagulation and New Anticoagulants. Now, we have even more anticoagulants and with all of the choices comes a lot of confusion. On this CME webcast, joining our moderator, to demystify all of the new anticoagulants and to give us some direction of when to choose one versus another is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Tzu-Fei Wang.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: State the differences of old anticoagulation and new direct oral anticoagulants and know the four approved direct oral anticoagulant; and UNDERSTAND the indications, laboratory testing, and precautions when prescribing direct oral anticoagulants.

You’ll also learn about the following:

  • The problem with Coumadin
  • Currently available direct oral anticoagulants
  • When Coumadin is the best option
  • Mitigating malpractice risk when prescribing direct oral anticoagulants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.